Delving into the Latest Updates on Beijing Shijitan Hospital Affiliated to Capital Medical University with Synapse

Overview

Tags

Other Diseases

Immune System Diseases

Nervous System Diseases

Recombinant polypeptide

CAR-T

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	4
Nervous System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Recombinant polypeptide	8
CAR-T	1

Top 5 Target	Count

ATP6AP1(ATPase H+ transporting accessory protein 1)	1
Hepc(Hepcidin)	1
RELT(RELT TNF receptor)	1
PDCD6IP(programmed cell death 6 interacting protein)	1
CRP(C-reactive protein)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

8

1

Preclinical

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

IL13RA2 targeted CAR-T (Beijing Shijitan Hospital) ( IL-13Rα2 )	Glioblastoma More	Preclinical
CN114252626 ( NECTIN1 )	Immune System Diseases More	Discovery
CN113804894 ( RELT )	Wounds and Injuries More	Discovery
CN113804890 ( PDCD6IP )	Wounds and Injuries More	Discovery
CN114252625 ( c-Kit )	Immune System Diseases More	Discovery